Aliza P. Wingo

Università di Camerino — Italy

Medicine · Health Sciences

44h-index6.7kcitations179works6.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(38), Genetic Associations and Epidemiology(32), Bioinformatics and Genomic Networks(29), Tryptophan and brain disorders(24), Dementia and Cognitive Impairment Research(22)

Publications178 total

Cerebrospinal Fluid Proteins as Biomarkers of Brain Vascular Injury
Alzheimer s & Dementia·2025Open Access
Cross‐ancestry prioritization of sex‐specific Alzheimer's disease risk genes through genetics and proteogenomics
Alzheimer s & Dementia·2025Open Access
Metabolic Dysregulation in Alzheimer's Disease: A High‐Resolution Brain Metabolomics Approach
Alzheimer s & Dementia·2025Open Access
Integrated Fair Machine Learning for Proteomic and Genomic Analysis Workflows
Alzheimer s & Dementia·2025Open Access
Integrative Genetic, Proteogenomic, and Multi-omics Analyses Reveal Sex-Biased Causal Genes and Drug Targets in Alzheimer’s Disease
2025· 2 citedOpen Access
Multi-scale integration of human brain vascular and CSF proteomes reveals biomarkers of cerebral amyloid angiopathy linked to Alzheimer’s disease risk
2025· 2 citedOpen Access
CSF proteogenomics implicates novel proteins and humoral immunity in Alzheimer’s disease risk
2025· 1 citedOpen Access
Response to the letter titled “Expanding the Horizon of Sex‐Specific Proteomic Insights in Alzheimer's Disease”
Alzheimer s & Dementia·2025Open Access
Multiancestry brain pQTL fine-mapping and integration with genome-wide association studies of 21 neurologic and psychiatric conditions
Nature Genetics·2025· 3 citedOpen Access
Metabolic dysregulation in Alzheimer's disease: A brain metabolomics approach
Alzheimer s & Dementia·2025· 2 citedOpen Access
Life Purpose Lowers Risk for Cognitive Impairment in a United States Population-Based Cohort
American Journal of Geriatric Psychiatry·2025· 1 citedOpen Access
Epigenome‐wide association study of cerebrospinal fluid–based biomarkers of Alzheimer's disease in cognitively normal individuals
Alzheimer s & Dementia·2025· 2 citedOpen Access
GWAS links <i>APOE</i> to neuropsychiatric symptoms in mild cognitive impairment and dementia
Alzheimer s & Dementia·2025Open Access
Unraveling sex differences in Alzheimer's disease and related endophenotypes with brain proteomes
Alzheimer s & Dementia·2025· 4 citedOpen Access
Differential DNA methylation in blood as potential mediator of the association between ambient PM <sub>2.5</sub> and cerebrospinal fluid biomarkers of Alzheimer’s disease among a cognitively normal population-based cohort
2025· 1 citedOpen Access
344. Multi-Ancestry Brain pQTL Fine-Mapping and Integration With GWAS of 21 Neurologic and Psychiatric Conditions
Biological Psychiatry·2025
Brain microRNAs differentially expressed in age-related cerebral pathologies
Neurobiology of Aging·2025· 2 cited
Structural variants linked to Alzheimer’s disease and other common age-related clinical and neuropathologic traits
Genome Medicine·2025· 7 citedOpen Access
Epigenome-wide association study of cerebrospinal fluid-based biomarkers of Alzheimer’s disease in cognitively normal individuals
2025· 1 citedOpen Access
GWAS links <i>APOE</i> to neuropsychiatric symptoms in mild cognitive impairment and dementia
2025Open Access
page 1 of 9Next →

Frequent Co-authors

Thomas S. Wingo(29), Allan I. Levey(20), David A. Bennett(15), Ekaterina S. Gerasimov(14), Nicholas T. Seyfried(14), Bekh Bradley(14), Kerry J. Ressler(14), Philip L. De Jager(13), James J. Lah(13), Duc M. Duong(13), Adriana Lori(10), Eric B. Dammer(9), Yue Liu(9), Thomas G. Beach(7), Michael P. Epstein(7), Ross J. Baldessarini(6), Tanja Jovanović(6), Erik C. B. Johnson(5), Benjamin A. Logsdon(5), Chloe Robins(5)